Hims & Hers (HIMS) officer plans $692K stock sale

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) received a notice that Soleil Boughton, an officer, intends to sell 25,111 shares of Class A common stock under Rule 144. The shares are held at Fidelity Brokerage Services LLC and relate to restricted stock awards scheduled to vest in 2025 and 2026.

The planned sale amount corresponds to restricted stock vesting of 2,707 shares on June 15, 2025, 18,946 shares on June 15, 2026, and 3,458 shares on August 15, 2026. As of this notice, Class A shares outstanding are reported as 224,935,790.

Key Figures

Shares to be sold: 25,111 shares Aggregate market value: $691,808.05 Shares outstanding: 224,935,790 shares +3 more

6 metrics

Shares to be sold 25,111 shares Total Class A shares covered by the Rule 144 notice for Soleil Boughton

Aggregate market value $691,808.05 Reported market value of the 25,111 Class A shares to be sold

Shares outstanding 224,935,790 shares Class A shares of Hims & Hers Health, Inc. reported as outstanding

Vesting tranche 1 2,707 shares Restricted stock vesting on June 15, 2025, classified as compensation

Vesting tranche 2 18,946 shares Restricted stock vesting on June 15, 2026, classified as compensation

Vesting tranche 3 3,458 shares Restricted stock vesting on August 15, 2026, classified as compensation

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact, Class A

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Class A | 06/15/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Soleil Boughton"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Class A financial

"Class A | Fidelity Brokerage Services LLC"

Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.

FAQ

What does the Form 144 for HIMS disclose about Soleil Boughton’s planned stock sale?

It discloses that Soleil Boughton, an officer, intends to sell 25,111 shares of Hims & Hers Health, Inc. Class A common stock under Rule 144, based on restricted stock awards vesting in 2025 and 2026.

How many HIMS shares are planned to be sold and at what reported value?

The notice covers 25,111 shares of HIMS Class A common stock, with a reported aggregate market value of approximately $691,808.05. This reflects the market value tied to the proposed Rule 144 sale at the time of the notice.

What are the vesting dates of the restricted stock underlying the HIMS Form 144?

The underlying restricted stock vests in three tranches: 2,707 shares on June 15, 2025, 18,946 shares on June 15, 2026, and 3,458 shares on August 15, 2026, all designated as compensation awards from the issuer.

How many Hims & Hers (HIMS) Class A shares are outstanding in this notice?

The notice reports that there are 224,935,790 Hims & Hers Health, Inc. Class A common shares outstanding. This figure provides context for the relative size of the proposed 25,111-share Rule 144 sale by Soleil Boughton.

Who is executing the planned HIMS share sale for Soleil Boughton?

The planned sale is associated with Fidelity Brokerage Services LLC, which is identified with the Class A securities to be sold. The Form 144 is signed by Daniel Tucci as attorney-in-fact and duly authorized representative of Fidelity for Soleil Boughton.

What is Rule 144 in the context of the HIMS Form 144 filing?

In this context, Rule 144 provides a framework under which an affiliate, such as officer Soleil Boughton, may resell restricted or control securities. The notice outlines intended sales and aggregation requirements for persons whose sales must be combined under the rule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 09:41 AM Accepted by SEC EDGAR 08/19/2026 - 09:41 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001837817
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 CHESTNUT ST #523 SAN FRANCISCO CALIFORNIA 94123
Phone	415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Boughton Soleil
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	25111	691808.05	224935790	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	06/15/2025	Restricted Stock Vesting	Issuer			2707	06/15/2025	Compensation
Class A	06/15/2026	Restricted Stock Vesting	Issuer			18946	06/15/2026	Compensation
Class A	08/15/2026	Restricted Stock Vesting	Issuer			3458	08/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Soleil Boughton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)